• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过自体CTL克隆检测到的人类黑色素瘤肿瘤的抗原异质性。

Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.

作者信息

Degiovanni G, Lahaye T, Hérin M, Hainaut P, Boon T

机构信息

Laboratoire de Chirurgie Expérimentale, Université de Liège, Belgium.

出版信息

Eur J Immunol. 1988 May;18(5):671-6. doi: 10.1002/eji.1830180503.

DOI:10.1002/eji.1830180503
PMID:2967757
Abstract

Peripheral blood lymphocytes from a melanoma patient were stimulated with autologous melanoma cells in mixed lymphocyte tumor cultures (MLTC). After three restimulations, the lytic activity of the responder cells directed against the autologous melanoma cells was higher than that against K-562 and autologous Epstein-Barr virus-transformed B cell line (EBV-B) cells. From these MLTC-responder cells, we derived specific cytolytic T cell (CTL) clones that lysed the autologous melanoma cells and did not lyse K-562 or autologous EBV-B cells. Autologous melanoma clones were found that were resistant to some or all of these CTL clones. The autologous CTL clones recognized at least two different antigens (A, B) on the melanoma cells and three types of melanoma clones could be distinguished (A+B+, A+B-, A-B-). This antigenic heterogeneity of melanoma clones was confirmed by testing the CTL clones in cold target competition and also in antigen-dependent CTL proliferation assays performed with very small numbers of stimulator cells. The data further indicated an instability of the expression of a melanoma-associated antigen in the course of a long culture period. Among the melanoma clones that expressed antigen A, one was found to stimulate the proliferation of anti-A CTL clones much more effectively than the others. This represents a new type of heterogeneity among tumor cells which may be of significance for the elicitation of an autologous anti-tumoral immune response.

摘要

在混合淋巴细胞肿瘤培养物(MLTC)中,用来自一名黑色素瘤患者的自体黑色素瘤细胞刺激外周血淋巴细胞。经过三次再刺激后,应答细胞针对自体黑色素瘤细胞的裂解活性高于针对K-562和自体爱泼斯坦-巴尔病毒转化的B细胞系(EBV-B)细胞的裂解活性。从这些MLTC应答细胞中,我们获得了特异性细胞毒性T细胞(CTL)克隆,这些克隆可裂解自体黑色素瘤细胞,但不能裂解K-562或自体EBV-B细胞。发现自体黑色素瘤克隆对部分或所有这些CTL克隆具有抗性。自体CTL克隆识别黑色素瘤细胞上至少两种不同的抗原(A、B),并且可以区分三种类型的黑色素瘤克隆(A+B+、A+B-、A-B-)。通过在冷靶竞争试验以及使用极少量刺激细胞进行的抗原依赖性CTL增殖试验中测试CTL克隆,证实了黑色素瘤克隆的这种抗原异质性。数据进一步表明,在长时间培养过程中,黑色素瘤相关抗原的表达不稳定。在表达抗原A的黑色素瘤克隆中,发现其中一个比其他克隆更有效地刺激抗A CTL克隆的增殖。这代表了肿瘤细胞之间一种新型的异质性,可能对引发自体抗肿瘤免疫反应具有重要意义。

相似文献

1
Antigenic heterogeneity of a human melanoma tumor detected by autologous CTL clones.通过自体CTL克隆检测到的人类黑色素瘤肿瘤的抗原异质性。
Eur J Immunol. 1988 May;18(5):671-6. doi: 10.1002/eji.1830180503.
2
Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.与自体黑色素瘤细胞反应的克隆化人细胞毒性T淋巴细胞(CTL)系。I. 体外生成、分离及表型和特异性分析。
J Immunol. 1984 Jan;132(1):510-9.
3
Antigens recognized on a melanoma cell line by autologous cytolytic T lymphocytes are also expressed on freshly collected tumor cells.自体溶细胞性T淋巴细胞在黑色素瘤细胞系上识别的抗原也在新鲜采集的肿瘤细胞上表达。
Eur J Immunol. 1990 Aug;20(8):1865-8. doi: 10.1002/eji.1830200835.
4
Diversity of the cytotoxic melanoma-specific immune response: some CTL clones recognize autologous fresh tumor cells and not tumor cell lines.细胞毒性黑色素瘤特异性免疫反应的多样性:一些细胞毒性T淋巴细胞(CTL)克隆识别自体新鲜肿瘤细胞而非肿瘤细胞系。
J Immunol. 1997 Apr 15;158(8):3787-95.
5
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction.来自外周血和肿瘤部位的细胞毒性T淋巴细胞克隆可检测黑色素瘤细胞的肿瘤内异质性。特异性及相互作用机制分析。
J Immunol. 1989 May 15;142(10):3692-701.
6
The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.HLA I类抗原在肿瘤特异性细胞毒性T淋巴细胞识别黑色素瘤细胞中的作用。共享肿瘤抗原的证据。
J Immunol. 1989 May 1;142(9):3329-35.
7
Human T cell clones exerting multiple cytolytic activities show heterogeneity in susceptibility to inhibition by monoclonal antibodies.表现出多种细胞溶解活性的人T细胞克隆在对单克隆抗体抑制的敏感性方面存在异质性。
J Immunol. 1984 Sep;133(3):1222-9.
8
Cytotoxic T cell clones isolated from ovarian tumor-infiltrating lymphocytes recognize multiple antigenic epitopes on autologous tumor cells.从卵巢肿瘤浸润淋巴细胞中分离出的细胞毒性T细胞克隆可识别自体肿瘤细胞上的多个抗原表位。
J Immunol. 1991 Mar 1;146(5):1700-7.
9
Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection.一位黑色素瘤患者的两次连续转移灶上,细胞毒性T细胞所识别的抗原差异与免疫选择相符。
Eur J Immunol. 1995 Feb;25(2):340-7. doi: 10.1002/eji.1830250206.
10
Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene.黑色素瘤上被自体细胞溶解T淋巴细胞识别的两种抗原源自一个关键管家基因中的单点突变。
Cancer Res. 1999 Nov 15;59(22):5785-92.

引用本文的文献

1
Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer.三阴性乳腺癌中细胞毒性淋巴细胞相关基因特征
J Pers Med. 2023 Feb 28;13(3):457. doi: 10.3390/jpm13030457.
2
The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy.MHC Class-I Transactivator NLRC5:对癌症免疫学的影响及在癌症免疫治疗中的潜在应用。
Int J Mol Sci. 2021 Feb 17;22(4):1964. doi: 10.3390/ijms22041964.
3
Current status of interleukin-10 and regulatory T-cells in cancer.白细胞介素-10 和调节性 T 细胞在癌症中的现状。
Curr Opin Oncol. 2013 Nov;25(6):637-45. doi: 10.1097/CCO.0000000000000006.
4
Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.肿瘤逃避免疫识别:一名患者出现致死性复发性黑色素瘤,与肽转运蛋白TAP-1下调及免疫显性抗原MART-1/Melan-A表达缺失相关。
J Clin Invest. 1996 Oct 1;98(7):1633-41. doi: 10.1172/JCI118958.
5
Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.对一名对主动特异性免疫疗法有反应的黑色素瘤患者体内活化的CD8 + 细胞毒性T淋巴细胞进行克隆分析。
Cancer Immunol Immunother. 1993 Jul;37(1):15-25. doi: 10.1007/BF01516937.
6
MHC antigen expression by melanomas recovered from mice treated with allogeneic mouse fibroblasts genetically modified for interleukin-2 secretion and the expression of melanoma-associated antigens.从用经基因改造可分泌白细胞介素-2并表达黑色素瘤相关抗原的同种异体小鼠成纤维细胞处理的小鼠中回收的黑色素瘤的MHC抗原表达。
Cancer Immunol Immunother. 1994 Mar;38(3):185-93. doi: 10.1007/BF01525640.
7
Frequency analysis of tumor-reactive cytotoxic T lymphocytes in peripheral blood of a melanoma patient vaccinated with autologous tumor cells.对接受自体肿瘤细胞疫苗接种的黑色素瘤患者外周血中肿瘤反应性细胞毒性T淋巴细胞的频率分析。
Cancer Immunol Immunother. 1994 Aug;39(2):93-9. doi: 10.1007/BF01525314.
8
Relevance of the T cell receptor for immunotherapy of cancer.T细胞受体在癌症免疫治疗中的相关性。
Cancer Immunol Immunother. 1994 Jul;39(1):1-14. doi: 10.1007/BF01517174.
9
Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression.原发性黑色素瘤中的肿瘤浸润淋巴细胞:白细胞介素-2受体差异表达的功能后果
Clin Exp Immunol. 1993 Jan;91(1):121-5. doi: 10.1111/j.1365-2249.1993.tb03365.x.
10
Human autologous tumor-specific T cells in malignant melanoma.恶性黑色素瘤中的人类自体肿瘤特异性T细胞。
Cancer Metastasis Rev. 1991 Jun;10(2):151-76. doi: 10.1007/BF00049412.